Manipulation of Leukocytes Using Therapeutic RNAi Delivered by Targeted and Stabilized Nanoparticles - Nanotechnology for the Delivery of Therapeutic Nucleic Acids - page 191

18. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P, .

Targeted delivery of small interfering RNA to human dendritic cells
to suppress dengue virus infection and associated proinflammatory
cytokine production.

et al

(5):2490-2501.
19. Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, Wu H,

J Virol , 2010; 84

. Targeted
delivery of siRNA to macrophages for anti-inflammatory treatment.
Mol Ther

et al

(5):993-1001.
20. Weinstein S, and Peer D. RNAi nanomedicines: challenges and
opportunities within the immune system.

, 2010; 18

Nanotechnology , 2010;

(23):232001.
21. Peer D. Induction of therapeutic gene silencing in leukocyte-implicated
diseases by targeted and stabilized nanoparticles: a mini-review.
J Control Release

21

(1):63-68.
22. Kedmi R, Ben-Arie N, and Peer D. The systemic toxicity of positively
charged lipid nanoparticles and the role of toll-like receptor 4 in
immune activation.

, 2010; 148

(26):6867-6875.
23. Peer D, Florentin A, and Margalit R. Hyaluronan is a key component
in cryoprotection and formulation of targeted unilamellar liposomes.
Biochim Biophys Acta

Biomaterials , 2010; 31

(1):76-82.
24. Kim SS, Peer D, Kumar P, Subramanya S, Wu H, Asthana D,

, 2003; 1612

. RNAi-
mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents
HIV infection in BLT mice.

et al

Mol Ther , 2010; 18 (2):370-376.